This guide covers everything researchers need to know: the current approval status, every TRIUMPH trial and what the data shows, the new safety signals that emerged, realistic timeline projections, and how retatrutide stacks up against the GLP-1 medications already on the market
Those experiencing unexplained symptoms, skin reactions, or signs of hypoglycaemia (dizziness, sweating, confusion) should seek prompt medical attention
Lancet Diabetes Endocrinol 8(5):436446
Psychiatry 16, 252264
We were interested in studying the effect of GLP-1 receptor agonists in uveitis, which is fundamentally an inflammatory eye disease, says Nitesh Mohan, a student at Cleveland Clinic Lerner College of Medicine who was lead author of the study
Answer a few questions about your health and goals